Public Release: 

2015 AACR-Rosenthal Award honors Dr. William Hahn

AACR, Rosenthal Family Foundation recognize Dr. William Hahn's groundbreaking contributions to cancer research

American Association for Cancer Research

PHILADELPHIA -- The American Association for Cancer Research (AACR) will recognize William C. Hahn, MD, PhD, with the 39th annual AACR-Richard and Hinda Rosenthal Memorial Award at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.

Hahn, who is the chief of the Division of Molecular and Cellular Oncology, chair of the Executive Committee for Research, and director of the Center for Cancer Genome Discovery at Dana-Farber Cancer Institute in Boston, is being honored for his seminal contributions to the understanding of the mechanisms underlying cancer initiation, maintenance, and progression. His work has defined new conceptual paradigms and has provided a foundation for novel therapeutic approaches that are now being tested in the clinic. Hahn's dedication and innovative approaches to cancer research are continuing to transform the field.

He will present his lecture, "Systematic Identification of Cancer Targets," Monday, April 20, 4:30 p.m. ET, in Terrace Ballroom II/III of the Pennsylvania Convention Center.

"This is a tremendous honor that I share with all of the members of my lab past and present," said Hahn, who is also associate professor of medicine at Harvard Medical School and an institute member of the Broad Institute of Harvard and MIT.

This award provides incentive to young investigators early in their careers, so it is stipulated that recipients be no older than 50 at the time the award is received. It was established in 1977 by the AACR and the Rosenthal Family Foundation to recognize research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer.

An active AACR member, Hahn is a senior editor of Molecular Cancer Research, and an editorial board member of Cancer Research and Cancer Discovery. Additionally, he recently co-chaired the 2015 AACR Special Conference: Translation of the Cancer Genome.

Hahn has been a member of the Harvard Medical School faculty throughout his career, which is where he also received his bachelor's, medical, and doctoral degrees. Additionally, he was a resident at Massachusetts General Hospital, a clinical fellow at the Dana-Farber Cancer Institute and Brigham and Women's Hospitals, and a postdoctoral fellow at the Whitehead Institute.


Press registration for the AACR Annual Meeting 2015 is free to qualified journalists and public information officers:

Follow the AACR Annual Meeting 2015 on Twitter: #AACR15

Follow us: Cancer Research Catalyst; Twitter @AACR; and Facebook

About the American Association for Cancer Research

Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in 101 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 25 conferences and educational workshops, the largest of which is the AACR Annual Meeting with over 18,500 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.